Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.

Model-based assessment of public health impact and cost-effectiveness of dengue vaccination following screening for prior exposure.

The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but recent findings indicate an elevated risk of severe disease among vaccinees without prior dengue virus (DENV) exposure. The World Health Organization currently recommends CYD-TDV only for individuals...

Full description

Bibliographic Details
Main Authors: Guido España, Yutong Yao, Kathryn B Anderson, Meagan C Fitzpatrick, David L Smith, Amy C Morrison, Annelies Wilder-Smith, Thomas W Scott, T Alex Perkins
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0007482

Internet

https://doi.org/10.1371/journal.pntd.0007482

Similar Items